共 50 条
- [21] EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIALJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E319 - E319Dudek, Dariusz
- [22] Absorb Bioresorbable Vascular Scaffold in Complex Coronary Bifurcation Interventions Insights From an In Vivo Multimodality Imaging StudyCIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (08)Bennett, JohanVanhaverbeke, MaartenVanden Driessche, NinaAdriaenssens, TomHiltrop, NickDesmet, WalterSinnaeve, PeterDubois, Christophe
- [23] 5-Year Clinical Results of a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions: Data From the ABSORB Japan TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B164 - B164Kozuma, KenKimura, TakeshiTanabe, Kengo
- [24] THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT BJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1706 - A1706Christiansen, Evald Hoej
- [25] First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery LesionsJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B11 - B11Chevalier, Bernard
- [26] 4-year Clinical Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions: Data from the ABSORB Japan TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B128 - B129Tanabe, KengoKozuma, KenKimura, Takeshi
- [27] Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B11 - B11Smits, Peter
- [28] Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold Final Report From the ABSORB Clinical Trial ProgramJACC-CARDIOVASCULAR INTERVENTIONS, 2025, 18 (01) : 1 - 11Power, David A.Camaj, AntonKereiakes, Dean J.Ellis, Stephen G.Gao, RunlinKimura, TakeshiAli, Ziad A.Stockelman, Kelly A.Dressler, OvidiuOnuma, YoshinobuSerruys, Patrick W.Stone, Gregg W.
- [29] ABSORB: EVALUATION OF THE BIORESORBABLE EVEROLIMUS-ELUTING VASCULAR SCAFFOLD (BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 1 YEAR ANGIOGRAPHIC, IVUS, IVUS-VH AND OCT RESULTS OF COHORT BJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1623 - E1623Serruys, Patrick W.
- [30] Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trialEUROINTERVENTION, 2017, 12 (14) : 1738 - 1746Ohya, MasanobuKadota, KazushigeSotomi, YoheiKozuma, KenTanabe, KengoUematsu, MasaakiKawasaki, TomohiroMorino, YoshihiroTobaru, TetsuyaNakao, KoichiTachibana, KouichiKishi, KoichiShibata, YoshisatoYing, ShihwaKusano, HajimeStone, Gregg W.Popma, Jeffery J.Onuma, YoshinobuSerruys, Patrick W.Kimura, Takeshi